Identification of gene markers for the prediction of allograft rejection or permanent acceptance

American Journal of Transplantation

Volumn 7, Issue 5, 2007, Pages 1091-1102

  Sawitzki, B ^a,b   Bushell, A ^b   Steger, U ^b   Jones, N ^b   Risch, K ^c   Siepert, A ^c   Lehmann, M ^c   Schmitt Knosalla, I ^a   Vogt, K ^a   Gebuhr, I ^a   Wood, K ^b   Volk, H D ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Gene expression; Rejection; T cell; Tolerance; Transplantation

Indexed keywords

ALPHA MANNOSIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLOGICAL MONITORING; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DOWN REGULATION; FEMALE; GENE; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC CORRELATION; GRAFT SURVIVAL; HEART GRAFT; IMMUNOLOGICAL TOLERANCE; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; LEUKOCYTE ACTIVATION; MALE; MARKER GENE; NONHUMAN; NUCLEOTIDE SEQUENCE; PREDICTION; PRIORITY JOURNAL; RAT; REPRODUCIBILITY; T LYMPHOCYTE ACTIVATION; TOAG 1 GENE;

ANIMALS; ANTIGENS, CD3; GENE EXPRESSION REGULATION; GENETIC MARKERS; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; KIDNEY TRANSPLANTATION; LEUKOCYTES; MALE; MANNOSIDASES; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; PORE FORMING CYTOTOXIC PROTEINS; PREDICTIVE VALUE OF TESTS; RATS; RATS, INBRED LEW; RATS, INBRED STRAINS; RNA, MESSENGER; TRANSPLANTATION, HOMOLOGOUS;

EID: 34247367270     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2007.01768.x     Document Type: Article

References (45)

1. Salama AD, Remuzzi G, Harmon WE, Sayegh MH. Challenges to achieving clinical transplantation tolerance. J Clin Invest 2001 108 : 943 948.
2. Calne R, Friend P, Moffatt S et al. Prope tolerance, perioperative campath 1H, and low-dose cyclosporin monotherapy in renal allograft recipients. Lancet 1998 351 : 1701 1702.
3. Herold KC, Hagopian W, Auger JA et al. Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus. N Engl J Med 2002 346 : 1692 1698.
4. Kirk AD, Hale DA, Mannon RB et al. Results from a human renal allograft tolerance trial evaluating the humanized CD52-specific monoclonal antibody alemtuzumab (CAMPATH-1H). Transplantation 2003 76 : 120 129.
5. Knechtle SJ, Pirsch JDH, Fechner JJ et al. Campath-1H induction plus rapamycin monotherapy for renal transplantation: results of a pilot study. Am J Transplant 2003 3 : 722 730.
6. Matthews JB, Ramos E, Bluestone JA. Clinical trials of transplant tolerance: slow but steady progress. Am J Transplant 2003 3 : 794 803.
7. Ossevoort MA, Ringers J, Kuhn EM et al. Prevention of renal allograft rejection in primates by blocking the B7/CD28 pathway. Transplantation 1999 68 : 1010 1018.
8. Spitzer TR, Delmonico F, Tolkoff-Rubin N et al. Combined histocompatibility leukocyte antigen-matched donor bone marrow and renal transplantation for multiple myeloma with end stage renal disease: the induction of allograft tolerance through mixed lymphohematopoietic chimerism. Transplantation 1999 68 : 480 484.
9. Thomas JM, Contreras JL, Jiang XL et al. Peritransplant tolerance induction in macaques: early events reflecting the unique synergy between immunotoxin and deoxyspergualin. Transplantation 1999 68 : 1660 1673.
10. Wekerle T, Kurtz J, Ito H et al. Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment. Nat Med 2000 6 : 464 469.
11. Herold KC, Gitelman SE, Masharani U et al. A single course of anti-CD3 monoclonal antibody hOKT3gamma1(Ala-Ala) results in improvement in C-peptide responses and clinical parameters for at least 2 years after onset of type 1 diabetes. Diabetes 2005 54 : 1763 1769.
12. Keymeulen B, Vandemeulebroucke E, Ziegler AG et al. Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes. N Engl J Med 2005 352 : 2598 2608.
13. Adams AB, Williams MA, Jones TR et al. Heterologous immunity provides a potent barrier to transplantation tolerance. J Clin Invest 2003 111 : 1887 1895.
14. Lakkis FG, Sayegh MH. Memory T cells: a hurdle to immunologic tolerance. J Am Soc Nephrol 2003 14 : 2402 2410.
15. Wu Z, Bensinger SJ, Zhang J et al. Homeostatic proliferation is a barrier to transplantation tolerance. Nat Med 2004 10 : 87 92.
16. Hernandez-Fuentes MP, Warrens AN, Lechler RI. Immunologic monitoring. Immunol Rev 2003 196 : 247 264.
17. Soulillou JP. Immune monitoring for rejection of kidney transplants. N Engl J Med 2001 344 : 1006 1007.
18. Stordeur P, Zhou L, Goldman M. Analysis of spontaneous mRNA cytokine production in peripheral blood. J Immunol Methods 2002 261 : 195 197.
19. Nickel P, Lacha J, Ode-Hakim S et al. Cytotoxic effector molecule gene expression in acute renal allograft rejection: correlation with clinical outcome; histopathology and function of the allograft. Transplantation 2001 72 : 1158 1160.
20. Sabek O, Dorak MT, Kotb M, Gaber AO, Gaber L. Quantitative detection of T-cell activation markers by real-time PCR in renal transplant rejection and correlation with histopathologic evaluation. Transplantation 2002 74 : 701 707.
21. Shulzhenko N, Morgun A, Zheng XX et al. Intragraft activation of genes encoding cytotoxic T lymphocyte effector molecules precedes the histological evidence of rejection in human cardiac transplantation. Transplantation 2001 72 : 1705 1708.
22. Strehlau J, Pavlakis M, Lipman M, Maslinski W, Shapiro M, Strom TB. The intragraft gene activation of markers reflecting T-cell-activation and -cytotoxicity analyzed by quantitative RT-PCR in renal transplantation. Clin Nephrol 1996 46 : 30 33.
23. Li B, Hartono C, Ding R et al. Noninvasive diagnosis of renal-allograft rejection by measurement of messenger RNA for perforin and granzyme B in urine. N Engl J Med 2001 344 : 947 954.
24. Simon T, Opelz G, Wiesel M, Ott RC, Susal C. Serial peripheral blood perforin and granzyme B gene expression measurements for prediction of acute rejection in kidney graft recipients. Am J Transplant 2003 3 : 1121 1127.
25. Saiura A, Mataki C, Murakami T et al. A comparison of gene expression in murine cardiac allografts and isografts by means DNA microarray analysis. Transplantation 2001 72 : 320 329.
26. Akalin E, Hendrix RC, Polavarapu RG et al. Gene expression analysis in human renal allograft biopsy samples using high-density oligoarray technology. Transplantation 2001 72 : 948 953.
27. Sarwal M, Chua MS, Kambham N et al. Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. N Engl J Med 2003 349 : 125 138.
28. Flechner SM, Kurian SM, Head SR et al. Kidney transplant rejection and tissue injury by gene profiling of biopsies and peripheral blood lymphocytes. Am J Transplant 2004 4 : 1475 1485.
29. Scherer A, Krause A, Walker JR, Korn A, Niese D, Raulf F. Early prognosis of the development of renal chronic allograft rejection by gene expression profiling of human protocol biopsies. Transplantation 2003 75 : 1323 1330.
30. Deng MC, Eisen HJ, Mehra MR et al. Noninvasive discrimination of rejection in cardiac allograft recipients using gene expression profiling. Am J Transplant 2006 6 : 150 160.
31. Hoffmann SC, Hale DA, Kleiner DE et al. Functionally significant renal allograft rejection is defined by transcriptional criteria. Am J Transplant 2005 5 : 573 581.
32. Sawitzki B, Lehmann M, Vogt K et al. Bag-1 up-regulation in anti-CD4 mAb treated allo-activated T cells confers resistance to apoptosis. Eur J Immunol 2002 32 : 800 809.
33. Corry RJ, Winn HJ, Russell PS. Primarily vascularized allografts of hearts in mice. The role of H-2D, H-2K, and non-H-2 antigens in rejection. Transplantation 1973 16 : 343 350.
34. Saitovitch D, Bushell A, Mabbs DW, Morris PJ, Wood KJ. Kinetics of induction of transplantation tolerance with a nondepleting anti-Cd4 monoclonal antibody and donor-specific transfusion before transplantation. A critical period of time is required for development of immunological unresponsiveness. Transplantation 1996 61 : 1642 1647.
35. Sawitzki B, Amersi F, Ritter T et al. Upregulation of Bag-1 by ex vivo gene transfer protects rat livers from ischemia/reperfusion injury. Hum Gene Ther 2002 13 : 1495 1504.
36. Lehmann M, Graser E, Risch K et al. Anti-CD4 monoclonal antibody-induced allograft tolerance in rats despite persistence of donor-reactive T cells. Transplantation 1997 64 : 1181 1187.
37. Kosuge T, Tamura T, Nariuchi H, Toyoshima S. Effect of inhibitors of glycoprotein processing on cytokine secretion and production in anti CD3-stimulated T cells. Biol Pharm Bull 2000 23 : 1 5.
38. Demetriou M, Granovsky M, Quaggin S, Dennis JW. Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation. Nature 2001 409 : 733 739.
39. Dennis JW, Pawling J, Cheung P, Partridge E, Demetriou M. UDP-N-acetylglucosamine:alpha-6-D-mannoside beta1,6 N- acetylglucosaminyltransferase V (Mgat5) deficient mice. Biochim Biophys Acta 2002 1573 : 414 422.
40. Morgan R, Gao G, Pawling J, Dennis JW, Demetriou M, Li B. N-acetylglucosaminyltransferase V (Mgat5)-mediated N-glycosylation negatively regulates Th1 cytokine production by T cells. J Immunol 2004 173 : 7200 7208.
41. Cobbold SP, Nolan KF, Graca L et al. Regulatory T cells and dendritic cells in transplantation tolerance: molecular markers and mechanisms. Immunol Rev 2003 196 : 109 124.
42. Zelenika D, Adams E, Humm S et al. Regulatory T cells overexpress a subset of Th2 gene transcripts. J Immunol 2002 168 : 1069 1079.
43. Matsui Y, Saiura A, Sugawara Y et al. Identification of gene expression profile in tolerizing murine cardiac allograft by costimulatory blockade. Physiol Genomics 2003 15 : 199 208.
44. Louvet C, Chiffoleau E, Heslan M et al. Identification of a new member of the CD20/FcepsilonRIbeta family overexpressed in tolerated allografts. Am J Transplant 2005 5 : 2143 2153.
45. Metcalfe SM, De SMPA. Transplantation tolerance: gene expression profiles comparing allotolerance vs. allorejection. Int Immunopharmacol 2005 5 : 33 39.